blee	10.1021/acs.molpharmaceut.6b00949	<http://dx.doi.org/10.1021/acs.molpharmaceut.6b00949>; rel="canonical", <http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00949>; version="vor"; rel="item", <http://orcid.org/0000-0002-4064-0999>; title="Won Jong Kim"; rel="author"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1021/acs.molpharmaceut.6b00949"><j.2:pageStart>1460</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jihyun-lee-37i407mocqdd0"><j.3:name>Jihyun Lee</j.3:name><j.3:familyName>Lee</j.3:familyName><j.3:givenName>Jihyun</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>1460</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/yeong-mi-lee-37i407mocqdd0"><j.3:name>Yeong Mi Lee</j.3:name><j.3:familyName>Lee</j.3:familyName><j.3:givenName>Yeong Mi</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.1021/acs.molpharmaceut.6b00949</j.2:doi><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1543-8384"><j.1:issn>1543-8392</j.1:issn><j.2:issn>1543-8392</j.2:issn><owl:sameAs>urn:issn:1543-8392</owl:sameAs><owl:sameAs>urn:issn:1543-8384</owl:sameAs><j.0:title>Molecular Pharmaceutics</j.0:title><j.1:issn>1543-8384</j.1:issn><j.2:issn>1543-8384</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/byung-joo-lee-37i407mocqdd0"><j.3:name>Byung Joo Lee</j.3:name><j.3:familyName>Lee</j.3:familyName><j.3:givenName>Byung Joo</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>1468</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jeong-hun-kim-37i407mocqdd0"><j.3:name>Jeong Hun Kim</j.3:name><j.3:familyName>Kim</j.3:familyName><j.3:givenName>Jeong Hun</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/won-jong-kim-37i407mocqdd0"><j.3:name>Won Jong Kim</j.3:name><j.3:familyName>Kim</j.3:familyName><j.3:givenName>Won Jong</j.3:givenName><owl:sameAs rdf:resource="http://orcid.org/0000-0002-4064-0999"/></j.3:Person></j.0:creator><j.1:endingPage>1468</j.1:endingPage><j.0:publisher>American Chemical Society (ACS)</j.0:publisher><j.0:identifier>10.1021/acs.molpharmaceut.6b00949</j.0:identifier><j.1:volume>14</j.1:volume><j.1:doi>10.1021/acs.molpharmaceut.6b00949</j.1:doi><owl:sameAs rdf:resource="doi:10.1021/acs.molpharmaceut.6b00949"/><owl:sameAs rdf:resource="info:doi/10.1021/acs.molpharmaceut.6b00949"/><j.0:title>Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing</j.0:title><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2017-02-22</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/hansoo-park-37i407mocqdd0"><j.3:name>Hansoo Park</j.3:name><j.3:familyName>Park</j.3:familyName><j.3:givenName>Hansoo</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>14</j.2:volume></rdf:Description></rdf:RDF>
